Summary
The stock has recorded a trading volume of 2,67,916 shares,. Its Average Traded Price (ATP) is ₹80.07, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 23 @ ₹80.18.
Lords Mark Industries has an upper circuit limit of ₹84.18 and a lower circuit limit of ₹76.18. The total value traded stands at ₹2.15 CR, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Lords Mark Industries also offers a dividend yield of 0%.
Lords Mark Industries Share Price Chart
Lords Mark Industries Share Key Metrics
Volume
2.68 L
Market Cap
3426.29 CR
LTQ@LTP
23@80.18
ATP
80.07
Var Margin
100 %
Circuit Range
76.18-84.18
Delivery %
100 %
Value
2.15 CR
ASM/GSM
No
Market Lot
1
Lords Mark Industries Resistance and Support
Pivot 82.08
Resistance
First Resistance
84.16
Second Resistance
87.48
Third Resistance
89.56
Support
First Support
78.76
Second Support
76.68
Third Support
73.36
Lords Mark Industries Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Lords Mark Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results & A.G.M. |
| 2026-08-06 | Others |
| 2026-05-30 | Audited Results |
| 2026-05-29 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-10-28 | Others |
| 2025-08-14 | Quarterly Results & A.G.M. |
| 2025-05-21 | Audited Results |
| 2025-03-21 | Others |
| 2025-01-24 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Lords Mark Industries News
Lords Mark Industries Ltd - 501261 - Re-Investment Of Funds Received From Sale Of 89,98,598 Equity Shares By Promoter Mr. Sachidanand Hariram Upadhyay For Medical Device Unit Expansion Of The Company.
Lords Mark promoter Sachidanand H Upadhyay sold 89,98,598 equity shares for Rs.76.18 crore via an open market transaction on September 29. He has confirmed plans to reinvest the majority of these proceeds into the company to expand its medical device unit.
Oct 01 2026 15:05:36
Lords Mark Industries Ltd - 501261 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Lords Mark promoter Sachidanand H Upadhyay sold 89,98,598 shares (2.11% stake) via the open market on September 29, 2026. Following this disposal, his holding in the company has decreased from 75.11% to 73.00%.
Oct 01 2026 10:28:14
Lords Mark Industries Ltd - 501261 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Sachidanand Hariram Upadhyay sold 89,98,598 shares (2.11% stake) in Lords Mark via the open market. Following this transaction, his total holding in the company has decreased from 75.11% to 73.00%.
Oct 01 2026 10:17:31
Lords Mark Industries Ltd - 501261 - Intimation Regarding Confirmation And Proposal Received From Promoter, Mr. Sachidanand Hariram Upadhyay For Re-Investment Of Funds Received From Sale Of Equity Shares Of The Company For Medical Device Unit Expansion.
Lords Mark promoter Mr. Sachidanand Hariram Upadhyay sold 1.03 crore shares for Rs. 87.38 crore on September 18, 2026. The promoter has proposed to reinvest the majority of these proceeds into the company's medical device unit expansion.
Sep 24 2026 08:31:53
Lords Mark Industries Ltd - 501261 - Intimation Titled 'Technical Committee Approves Final Clinical Trial Stage; Company Targets Regulatory Clearances And Commercial Launch By April 2027'
Lords Mark's AI-powered breast cancer screening technology has progressed to its final clinical trial stage. The company aims for regulatory clearances and commercial launch by April 2027, with Phase 2 trials starting Jan 2027 in US, Europe, and Great Britain.
Sep 23 2026 08:33:19
Lords Mark Industries Ltd - 501261 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Lords Mark promoter Sachidanand H. Upadhyay sold 1.03 crore equity shares of the company. This disposal reduced the promoter's stake by 2.43%, from 77.54% to 75.11% on September 18, 2026.
Sep 22 2026 12:51:52
Lords Mark Industries Ltd - 501261 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Completion Of Phase I Expansion At Silvassa Facility Ahead Of Schedule.
Lords Mark Industries completed Phase I expansion of its Silvassa facility ahead of the December 2026 schedule. This expands its surgical and orthopaedic product portfolio by 18 new SKUs, with commercial operations starting October 11, 2026.
Sep 16 2026 10:19:34
Lords Mark Industries Management
| Name | Position |
|---|---|
| Nikhil Pandey | Independent Non-Executive Director |
| Sachidanand Hariram Upadhyay | Managing Director |
Lords Mark Industries Similar Stocks
ICRA Ltd.
4427.95
129.10 (3.00%)
AYE Finance Ltd.
157.65
-2.55 (1.59%)
Fedbank Financial Services Ltd
146.25
0.95 (0.65%)
DCB Bank Ltd.
204.00
7.15 (3.63%)
Anand Rathi Share & Stock Brokers Ltd.
544.50
6.65 (1.24%)
RattanIndia Enterprises Ltd.
25.01
-0.02 (0.08%)
Muthoot Microfin Ltd.
168.10
-0.10 (0.06%)
Indostar Capital Finance Ltd.
188.25
-8.65 (4.39%)
Fino Payments Bank Ltd.
140.15
-6.15 (4.20%)
Lords Mark Industries FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in LORDSMARK
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC